Further, patients demonstrate high prevalence of BRCA mutations in triple negative breast cancer (TNBC), which is negative for estrogen receptors (ER-), progesterone receptors (PR-), and excess human epidermal growth factor receptor 2 (HER2) proteins. The gene discussed is PGR; the disease is triple-negative breast carcinoma.